Noerr and Pinsent Masons and Tautz & Schuhmacher provided advice on this deal.
Noerr advised the Bavarian State Ministry for Economic Affairs, Regional Development and Energy and Pinsent Masons advised GNA Biosolutions. In addition, Patent Attorney Dr Raphael Tautz at Tautz & Schuhmacher intellectual property law firm advised GNA Biosolutions on intellectual property aspects of the recent contract with the Bavarian Ministry of Economic Affairs to secure GNA’s
interests and protect the exclusivity of GNA’s know-how and patent portfolio. The Munich-based intellectual property law firm Tautz &
Schuhmacher has a strong focus on advising innovation-driven startup companies and is active in carrying out IP due diligence
and counselling on licensing contracts. Tautz & Schuhmacher has regularly represented and advised GNA Biosolutions in intellectual property matters over the past years. The subject of the contract is the development of COVID-19 rapid tests according to the PCR standard and the corresponding portable devices. It only takes 40 minutes from the throat swab to the result. The Federal Institute for Drugs and Medical Devices has granted the rapid test special approval. The Bavarian state government wants to use the test from January.
